Research Paper Volume 13, Issue 5 pp 6936—6944

Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China

bRFS outcome in patients treated with hypofractionated IG-VMAT versus conventionally fractionated IG-VMAT. bRFS, biochemical relapse–free survival; IG, imaging-guided; volumetric-modulated arc therapy, VMAT.

Figure 3. bRFS outcome in patients treated with hypofractionated IG-VMAT versus conventionally fractionated IG-VMAT. bRFS, biochemical relapse–free survival; IG, imaging-guided; volumetric-modulated arc therapy, VMAT.